Publications by authors named "James Weatherall"

Claim this Profile
I
Implementation of a data science and artificial intelligence strategy across pharmaceutical R&D: challenges and solutions.
Vincenzo Garzya, Gabriella Rustici, Tom Diethe, Peder Blomgren, Nina Mian, James Weatherall

Drug Discov Today· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable.
Najat S Khan, Thomas Senderovitz, James Weatherall, Janice Branson, Benedikt Egersdoerfer

Nat Rev Drug Discov· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities.
Alicia Curth, Richard W Peck, Eoin McKinney, James Weatherall, Mihaela van der Schaar

Clin Pharmacol Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical analysis for explosives detection system test and evaluation.
Stefan Lukow, James C Weatherall

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relative efficiency of schizophrenia health care systems: an international comparison using data envelopment analysis.
James Weatherall, Jacob Simonsen, Brian L Odlaug

J Med Econ· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning for clinical trials in the era of COVID-19.
William R Zame, Ioana Bica, Cong Shen, Alicia Curth, Hyun-Suk Lee, James Weatherall

Stat Biopharm Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker data visualisation for decision making in clinical trials.
Alan Davies, Marisa Cunha, Kamilla Kopec-Harding, Paul Metcalfe, James Weatherall

Int J Med Inform· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why We Trust Lies.
James Weatherall, Cailin O'Connor

Sci Am· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia.
Nicola Germain, Steven Kymes, Elin Löf, Anna Jakubowska, Clément François, James Weatherall

J Med Econ· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing prognostic and predictive biomarkers: an information theoretic approach.
Konstantinos Sechidis, Konstantinos Papangelou, Paul D Metcalfe, David Svensson, James Weatherall

Bioinformatics· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing prognostic and predictive biomarkers: an information theoretic approach.
Konstantinos Sechidis, Konstantinos Papangelou, Paul D Metcalfe, David Svensson, James Weatherall

Bioinformatics· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tendril Plot-a novel visual summary of the incidence, significance and temporal aspects of adverse events in clinical trials.
Martin Karpefors, James Weatherall

J Am Med Inform Assoc· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Tracking and Exercise in Patients With Type 2 Diabetes Mellitus (Step-D): Pilot Study to Determine Correlations Between Fitbit Data and Patient-Reported Outcomes.
James Weatherall, Yurek Paprocki, Theresa M Meyer, Ian Kudel, Edward A Witt

JMIR Mhealth Uhealth· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Lane et al., Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables.
Ws Lane, James Weatherall, Jens Gundgaard, Richard F Pollock

J Med Econ· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation.
James Weatherall, William H Polonsky, Sally Lanar, Naomi Knoble, Jonas Håkan-Bloch

Health Qual Life Outcomes· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables.
Wendy S Lane, James Weatherall, Jens Gundgaard, Richard F Pollock

J Med Econ· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of severe hypoglycemia in type 2 diabetes.
Jieruo Liu, Rosa Wang, Michael L Ganz, Yurek Paprocki, Doron Schneider, James Weatherall

Curr Med Res Opin· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of severe hypoglycemia in type 1 diabetes.
Jieruo Liu, Rosa Wang, Michael L Ganz, Yurek Paprocki, Doron Schneider, James Weatherall

Curr Med Res Opin· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of postprandial and fasting plasma glucose with HbA1c across the spectrum of glycaemic impairment in type 2 diabetes.
Paul Valensi, Lise Lotte N Husemoen, James Weatherall, Louis Monnier

Int J Clin Pract· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disentangling Prognostic and Predictive Biomarkers Through Mutual Information.
Konstantinos Sechidis, Emily Turner, Paul Metcalfe, James Weatherall, Gavin Brown

Stud Health Technol Inform· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine.
James Weatherall, Lisa Bloudek, Sarah Buchs

Curr Med Res Opin· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It's a long shot, but it just might work! Perspectives on the future of medicine.
Paul Wicks, Matthew Hotopf, Vaibhav A Narayan, Ethan Basch, James Weatherall

BMC Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA.
Meryl Brod, Annie Nikolajsen, James Weatherall, Kathryn M Pfeiffer

Diabetes Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries.
Meryl Brod, Annie Nikolajsen, James Weatherall, Kathryn M Pfeiffer

Diabetes Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Raman and Infrared Vibrational Motions of Erythritol Tetranitrate.
Jeffrey B Oleske, Barry T Smith, Jeffrey Barber, James C Weatherall

Appl Spectrosc· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis